Location History:
- Bayside, NY (US) (2000)
- Colts Neck, NJ (US) (1999 - 2016)
Company Filing History:
11 out of 545 
7 out of 9 
4 out of 32 
Years Active: 1999-2016
Title: **Frank S. Caruso: A Pioneer in Abuse-Resistant Opioid Solutions**
Introduction
Frank S. Caruso, based in Colts Neck, NJ, is a notable inventor with an impressive portfolio of 22 patents. He has significantly contributed to the field of pharmaceuticals, particularly focusing on the development of abuse-resistant opioid formulations.
Latest Patents
Among his latest innovations is the patented "Abuse-resistant controlled-release opioid dosage form." This formulation features a combination of an opioid antagonist, such as naloxone, designed to counteract the euphoric effects of opioids when misused. If the tablets are crushed, the controlled-release characteristics are disrupted, leading to an immediate release of both the opioid and antagonist. Importantly, the controlled release mechanism prevents the accumulation of effective amounts of the opioid antagonist when taken as intended. This innovative approach aims to address the pressing issue of opioid abuse while ensuring that patients still receive therapeutic benefits.
Career Highlights
Frank S. Caruso has held significant positions in various pharmaceutical companies, including Purdue Pharma L.P. and Algos Pharmaceutical Corporation. His dedication to advancing drug formulations has positioned him as a key player in the ongoing efforts to combat the opioid crisis through innovative pharmaceutical solutions.
Collaborations
Throughout his career, Frank has collaborated with esteemed colleagues such as Huai-Hung D. Kao and Fredrick L. Minn. These partnerships have fostered the exchange of ideas and the development of groundbreaking products within the pharmaceutical industry.
Conclusion
Frank S. Caruso's contributions to the field of pharmaceuticals, particularly with his abuse-resistant opioid formulations, highlight the importance of innovation in addressing public health challenges. With his extensive patent portfolio and collaboration with leading professionals, he continues to make a significant impact on the fight against opioid abuse while promoting safer medication practices.